Judge Backs Acorda's $16.6M Award In MS Drug Row

By Hannah Albarazi · August 7, 2023, 10:33 PM EDT

A New York federal judge has confirmed a nearly $16.6 million arbitral award issued to Acorda Therapeutics Inc. in its dispute with Alkermes PLC over a multiple sclerosis drug, but refused to...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Acorda Therapeutics, Inc. v. Alkermes plc

Case Number

1:23-cv-00223

Court

New York Southern

Nature of Suit

Other Statutes: Arbitration

Date Filed

January 10, 2023